Lv1
20 积分 2026-03-24 加入
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9
1个月前
已完结
Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer
4个月前
已完结
Discovery of Bi-magnolignan as a novel BRD4 inhibitor inducing apoptosis and DNA damage for cancer therapy
4个月前
已完结
Targeting cancer with small molecule pan-KRAS degraders
5个月前
已完结
皖公网安备34019202002308
